Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors because of government incentives, says Dr Mike Tubbs.
from Moneyweek RSS Feed https://moneyweek.com/investments/stocks-and-shares/share-tips/604876/biotech-stocks-curing-rare-diseases
via IFTTT
Subscribe to:
Post Comments (Atom)
-
The new strain of covid found in South Africa could disrupt plans by governments and central banks to rebuild economies. Financial markets a...
-
Fidelity “FIS” is a global financial services technology company and a leader in providing technology solutions to merchants, banks and cap...
-
Asian Equities Sink on Covid FearsIt’s been a mixed start to the week for global equities benchmarks with US and European asset markets rema...
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.